These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17312136)

  • 1. Increased positive selection of B1 cells and reduced B cell tolerance to intracellular antigens in c1q-deficient mice.
    Ferry H; Potter PK; Crockford TL; Nijnik A; Ehrenstein MR; Walport MJ; Botto M; Cornall RJ
    J Immunol; 2007 Mar; 178(5):2916-22. PubMed ID: 17312136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C1q deficiency promotes the production of transgenic-derived IgM and IgG3 autoantibodies in anti-DNA knock-in transgenic mice.
    Fossati-Jimack L; Cortes-Hernandez J; Norsworthy PJ; Walport MJ; Cook HT; Botto M
    Mol Immunol; 2008 Feb; 45(3):787-95. PubMed ID: 17675234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional definition of a B cell epitope, KGEQGEPGA, on C1q the Fc-binding subunit of the first component of complement.
    Trinder PK; Märker-Hermann E; Loos M; Maeurer MJ
    Scand J Immunol; 1999 Dec; 50(6):635-41. PubMed ID: 10607312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monocytosis and accelerated activation of lymphocytes in C1q-deficient autoimmune-prone mice.
    Trendelenburg M; Manderson AP; Fossati-Jimack L; Walport MJ; Botto M
    Immunology; 2004 Sep; 113(1):80-8. PubMed ID: 15312138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerance through indifference: autoreactive B cells to the nuclear antigen La show no evidence of tolerance in a transgenic model.
    Aplin BD; Keech CL; de Kauwe AL; Gordon TP; Cavill D; McCluskey J
    J Immunol; 2003 Dec; 171(11):5890-900. PubMed ID: 14634099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of autoimmunity in a transgenic model of B cell receptor peripheral tolerance: changes in coreceptors and B cell receptor-induced tyrosine-phosphoproteins.
    Feuerstein N; Chen F; Madaio M; Maldonado M; Eisenberg RA
    J Immunol; 1999 Nov; 163(10):5287-97. PubMed ID: 10553051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B cell tolerance to epidermal ribonuclear-associated neo-autoantigen in vivo.
    Degn SE; Alicot E; Carroll MC
    Clin Exp Immunol; 2018 Feb; 191(2):151-165. PubMed ID: 28984923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C1q and systemic lupus erythematosus.
    Walport MJ; Davies KA; Botto M
    Immunobiology; 1998 Aug; 199(2):265-85. PubMed ID: 9777411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MMP-9/Gelatinase B Degrades Immune Complexes in Systemic Lupus Erythematosus.
    Ugarte-Berzal E; Boon L; Martens E; Rybakin V; Blockmans D; Vandooren J; Proost P; Opdenakker G
    Front Immunol; 2019; 10():538. PubMed ID: 30967870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C1q, autoimmunity and apoptosis.
    Botto M; Walport MJ
    Immunobiology; 2002 Sep; 205(4-5):395-406. PubMed ID: 12396002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen localization within the splenic marginal zone restores humoral immune response and IgG class switch in complement C4-deficient mice.
    Zachrau B; Finke D; Kropf K; Gosink HJ; Kirchner H; Goerg S
    Int Immunol; 2004 Dec; 16(12):1685-90. PubMed ID: 15477230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgM antibodies to apoptosis-associated determinants recruit C1q and enhance dendritic cell phagocytosis of apoptotic cells.
    Chen Y; Park YB; Patel E; Silverman GJ
    J Immunol; 2009 May; 182(10):6031-43. PubMed ID: 19414754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of dead cell clearance in the etiology and pathogenesis of systemic lupus erythematosus: dendritic cells as potential targets.
    Biermann MH; Veissi S; Maueröder C; Chaurio R; Berens C; Herrmann M; Munoz LE
    Expert Rev Clin Immunol; 2014 Sep; 10(9):1151-64. PubMed ID: 25081199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IGM is required for efficient complement mediated phagocytosis of apoptotic cells in vivo.
    Ogden CA; Kowalewski R; Peng Y; Montenegro V; Elkon KB
    Autoimmunity; 2005 Jun; 38(4):259-64. PubMed ID: 16206508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies in systemic autoimmune diseases: specificity and pathogenicity.
    Suurmond J; Diamond B
    J Clin Invest; 2015 Jun; 125(6):2194-202. PubMed ID: 25938780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-C1q autoantibodies amplify pathogenic complement activation in systemic lupus erythematosus.
    Holers VM
    J Clin Invest; 2004 Sep; 114(5):616-9. PubMed ID: 15343378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B and T cell tolerance and autoimmunity in autoantibody transgenic mice.
    Yan J; Mamula MJ
    Int Immunol; 2002 Aug; 14(8):963-71. PubMed ID: 12147633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human complement Factor H modulates C1q-mediated phagocytosis of apoptotic cells.
    Kang YH; Urban BC; Sim RB; Kishore U
    Immunobiology; 2012 Apr; 217(4):455-64. PubMed ID: 22088229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C1q knock-out mice for the study of complement deficiency in autoimmune disease.
    Botto M
    Exp Clin Immunogenet; 1998; 15(4):231-4. PubMed ID: 10072632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultraviolet-radiation-induced keratinocyte apoptosis in C1q-deficient mice.
    Pickering MC; Fischer S; Lewis MR; Walport MJ; Botto M; Cook HT
    J Invest Dermatol; 2001 Jul; 117(1):52-8. PubMed ID: 11442749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.